SLCO4A1 and Alzheimer disease: The results showed a significant enhancement in the expression of NFKBIA, CLIC1, SLCO4A1 and TRAF3IP2, while the expression of PLCE1 was observed to be decreased in the AD model (Figure 11E–11I).